● Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Condition: Intermediate Risk Non-Muscle Invasive Bladder Cancer · Sponsor: Ferring Pharmaceuticals

PhasePhase 3

Planned participants454

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)

This description comes directly from the study's public registry record.

Talk to the study team

Ferring Pharmaceuticals · 833-548-1402 · disclosure@ferring.com

Always discuss trial participation with your own doctor first.

Locations (103)

University of South Alabama (USA) Health System - USACM	Mobile, Alabama, United States	Recruiting
Urology Associates of Mobile	Mobile, Alabama, United States	Recruiting
Mayo Clinic Arizona	Phoenix, Arizona, United States	Recruiting
Center for Neurosciences	Tucson, Arizona, United States	Recruiting
Arkansas Urology, North Little Rock	Little Rock, Arkansas, United States	Recruiting
Michael G Oefelein, MD Clinical Trials	Bakersfield, California, United States	Recruiting
Urology Associates of Central California	Fresno, California, United States	Recruiting
American Institute of Research	Los Angeles, California, United States	Recruiting
Urology Center of Southern California	Murrieta, California, United States	Recruiting
University of California, Irvine	Orange, California, United States	Recruiting
Providence Saint John's Cancer Institute	Santa Monica, California, United States	Recruiting
Advent Health	Denver, Colorado, United States	Recruiting

+ 91 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06510374